3
Clinical Trials associated with REGEND003 / Not yet recruitingPhase 1 An Exploratory Study of REGEND003 Kidney Progenitor Cells on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
REGEND003, which consists of human kidney progenitor cells, demonstrates promising potential in repairing kidney injury. The purpose of this study is to assess the saftey and tolerability of REGEND003 on patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease. It is an exploratory study with multi-centered, randomized, controlled, single-blinded, dose-escalated designs.
/ Not yet recruitingPhase 1IIT An Exploratory Study of REGEND003 Kidney Progenitor Cells on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
/ Not yet recruitingPhase 1 REGEND003细胞自体回输制剂治疗2型糖尿病合并CKD的探索性临床研究
[Translation] An exploratory clinical study of REGEND003 autologous cell infusion preparation for the treatment of type 2 diabetes mellitus complicated with CKD.
评价REGEND003细胞自体回输制剂治疗2型糖尿病合并CKD的安全性、耐受性。
[Translation] To evaluate the safety and tolerability of REGEND003 autologous cell infusion preparation for the treatment of type 2 diabetes mellitus complicated with CKD.
100 Clinical Results associated with REGEND003
100 Translational Medicine associated with REGEND003
100 Patents (Medical) associated with REGEND003
100 Deals associated with REGEND003